AE Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.3M Buy
927,590
+154,639
+20% +$1.88M 0.05% 301
2026
Q1
$10.8M Buy
772,951
+370,041
+92% +$5.19M 0.06% 285
2025
Q4
$5.8M Buy
402,910
+178,774
+80% +$2.69M 0.03% 371
2025
Q3
$3.57M Sell
224,136
-9,614
-4% -$158K 0.02% 421
2025
Q2
$4.14M Buy
233,750
+65,251
+39% +$1.27M 0.03% 381
2025
Q1
$3.51M Buy
168,499
+19,110
+13% +$362K 0.03% 414
2024
Q4
$2.76M Buy
149,389
+14,374
+11% +$276K 0.02% 461
2024
Q3
$2.65M Buy
135,015
+23,149
+21% +$461K 0.02% 458
2024
Q2
$2.19M Sell
111,866
-1,077
-1% -$20.4K 0.02% 497
2024
Q1
$2.03M Sell
112,943
-2,062
-2% -$37.4K 0.02% 484
2023
Q4
$2.08M Sell
115,005
-17,189
-13% -$342K 0.01% 891
2023
Q3
$2.63M Sell
132,194
-33,479
-20% -$634K 0.02% 755
2023
Q2
$3.11M Sell
165,673
-32,349
-16% -$652K 0.02% 698
2023
Q1
$4.04M Sell
198,022
-26,109
-12% -$525K 0.03% 561
2022
Q4
$4.75M Buy
224,131
+30,668
+16% +$636K 0.03% 491
2022
Q3
$3.93M Buy
193,463
+8,251
+4% +$164K 0.03% 481
2022
Q2
$4.03M Sell
185,212
-102,803
-36% -$2.07M 0.03% 449
2022
Q1
$5.28M Buy
+288,015
New +$5.31M 0.04% 424
2021
Q3
Sell
-38,532
Closed -$652K 1634
2021
Q2
$652K Buy
38,532
+21,324
+124% +$361K 0.01% 1028
2021
Q1
$295K Buy
17,208
+2,471
+17% +$44.3K ﹤0.01% 1256
2020
Q4
$281K Buy
14,737
+829
+6% +$17.3K ﹤0.01% 1168
2020
Q3
$328K Buy
13,908
+2,898
+26% +$69.4K ﹤0.01% 1012
2020
Q2
$268K Sell
11,010
-8,538
-44% -$211K ﹤0.01% 1063
2020
Q1
$502K Buy
+19,548
New +$465K 0.01% 677
2019
Q4
Sell
-15,917
Closed -$377K 1133
2019
Q3
$377K Buy
15,917
+4,387
+38% +$102K 0.01% 695
2019
Q2
$253K Hold
11,530
0.01% 815
2019
Q1
$249K Buy
+11,530
New +$245K 0.02% 524

Other funds holding BTAL

AE Wealth Management's BTAL Position: Q2 2026 in Review

AE Wealth Management increased its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 20% in Q2 2026, buying an estimated $1.88M and bringing the position to 927,590 shares worth $10.3M. The position accounts for 0.05% of the portfolio, ranked #301.

AE Wealth Management first reported a position in BTAL in Q1 2019 and has held it in 27 quarters since. The position peaked at $10.8M in Q1 2026. 48 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • AE Wealth Management held 927,590 shares of AGF US Market Neutral Anti-Beta Fund worth $10.3M as of Q2 2026.
  • AE Wealth Management bought 154,639 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $1.88M.
  • AGF US Market Neutral Anti-Beta Fund made up 0.05% of AE Wealth Management's portfolio in Q2 2026, its #301 holding.
  • AE Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q1 2019 and has held it in 27 quarters since.
  • AE Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $10.8M in Q1 2026.
  • 48 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on AE Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.